Vistaseal Solution
Product Images NDC 61953-0020

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Vistaseal (NDC 61953-0020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tyvek Label (Tyveklabel)

Label for VISTASEAL frozen solution, a topical plasma derivative containing human fibrinogen (80 mg/mL) and human thrombin (500 IU/mL). The label details two pre-filled syringes with sterile frozen solutions, includes storage instructions, and displays the 2 mL volume. Manufactured by Instituto Grifols, S.A. for GRIFOLS USA, LLC.*

FDA Label Image

Carton (Box Label)

Packaging label for VISTASEAL 2 mL solution, a fibrin sealant (human) containing human fibrinogen and human thrombin for topical use. The label shows 2 pre-filled syringes with sterile frozen solutions and one dual applicator. Distributed by Ethicon, manufactured by Instituto Grifols, with storage instructions and NDC 61953-0020-1.*

FDA Label Image

Figure 1 (Figure 1 Sm)

An instructional illustration showing two hands assembling or preparing a medical syringe or applicator device, which is likely used for administration of VISTASEAL topical solution containing human fibrinogen and human thrombin. The image emphasizes proper handling during preparation.*

FDA Label Image

Figure 2 (Figure 2)

An instructional illustration showing a syringe submerged in a liquid bath with temperature guidance. It notes the syringe should be set at 37°C and not exceed 39°C, with a timing indication of 5 to 10 minutes and a sterility note. This appears to demonstrate proper warming or incubation conditions for the product.*

FDA Label Image

Figure 3 (Figure 3 Sm)

An instructional diagram showing the removal of two small cap components from a dual-chamber container or device. Arrows indicate the direction in which the caps are to be pulled off, suggesting a preparatory step for use.*

FDA Label Image

Figure 4 (Figure 4 Sm)

An instructional illustration showing hands holding and assembling a dual-chamber device, likely representing preparation or use of a topical solution product such as VISTASEAL, a human fibrinogen and thrombin plasma derivative. The device has visible chambers and a locking or mixing mechanism at the base.*

FDA Label Image

Figure 5 (Figure 5 Sm)

Illustration showing two hands assembling or connecting a medical device consisting of a syringe and an adjoining component, possibly related to the administration or preparation of VISTASEAL topical solution containing human fibrinogen and human thrombin.*

FDA Label Image

Figure 6 (Figure 6)

An instructional illustration showing two solution bottles connected to a device marked 'VISTASEAL' with tubing. A hand holding a syringe is crossed out with a prohibition sign, indicating that the syringe should not be used in this setup.*

FDA Label Image

Figure 7 (Figure 7 Sm)

An instructional illustration showing two hands connecting medical device components, likely parts of a syringe or applicator. One hand holds a syringe-like device with a rotating or twisting motion indicated, while the other hand holds a cap or connector being attached. No text or branding is visible in the image.*

FDA Label Image

Figure 8 (Figure 8 Sm)

An illustration showing correct versus incorrect handling of a syringe-like device. The left side, marked with a check, demonstrates the proper position without bending, while the right side, marked with an X, shows incorrect handling involving an arrow indicating bending of the device near the tip.*

FDA Label Image

Figure 9 (Figure 9 Sm)

Illustration of VISTASEAL delivery components including a syringe holder with pre-filled syringes, plungers, syringe Luer caps, an adapter with Luer locks, a dual applicator, spray and drip tip, and airless spray tips. The diagram identifies each component by label to show assembly and use.*

FDA Label Image

Fibrinogen (Label Fibrinogen)

Label for VistaSeal Fibrinogen topical solution containing 80 mg/mL in a 1 mL volume. The label shows the product name, active ingredient fibrinogen, concentration, and lot and expiration date placeholders. The label uses blue and red text on a light blue background with a peach border.*

FDA Label Image

Thrombin (Label Thrombin)

The label displays VistaSeal Thrombin 500 IU/mL in a 1 mL solution form. It includes the lot number and expiration date area with the code 3062007 visible. The label background is light blue with dark blue text and a rounded border.*

FDA Label Image

Removable Seal (Revmovableseal)

Vistaseal 2 mL vial labels showing removable sections for lot number, expiration date, and thawed expiration date, all with lot number 3055495. The product is a topical plasma derivative solution containing human fibrinogen and human thrombin, labeled by GRIFOLS USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.